BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$14.25
−0.80%Margins
Gross margin
68.0%
EBITDA margin
16.0%
EBIT margin
10.6%
Net margin
9.4%
FCF margin
16.2%
23.9%
Return on equity
8.1%
Return on assets
12.6%
Return on invested capital
0.88x
Asset turnover
$96.9M
Cash from operations
$0.43
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026